According to Vertex Pharmaceuticals's latest financial reports the company has $17.58 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $17.58 B | 26.36% |
2022-12-31 | $13.91 B | 37.75% |
2021-12-31 | $10.10 B | 16.27% |
2020-12-31 | $8.68 B | 42.75% |
2019-12-31 | $6.08 B | 37.2% |
2018-12-31 | $4.43 B | 117.17% |
2017-12-31 | $2.04 B | 52.62% |
2016-12-31 | $1.33 B | 22.36% |
2015-12-31 | $1.09 B | -0.23% |
2014-12-31 | $1.09 B | -19.18% |
2013-12-31 | $1.35 B | 13.43% |
2012-12-31 | $1.19 B | 28.8% |
2011-12-31 | $0.92 B | 84.23% |
2010-12-31 | $0.50 B | -54.03% |
2009-12-31 | $1.09 B | 358.96% |
2008-12-31 | $0.23 B | -11.95% |
2007-12-31 | $0.27 B | -46.38% |
2006-12-31 | $0.50 B | 111.53% |
2005-12-31 | $0.23 B | 574.86% |
2004-12-31 | $35.44 M | -81.62% |
2003-12-31 | $0.19 B | -49.06% |
2002-12-31 | $0.37 B | -20.36% |
2001-12-31 | $0.47 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $68.77 B | 291.20% | ๐บ๐ธ USA |
AbbVie ABBV | $10.39 B | -40.86% | ๐บ๐ธ USA |
Gilead Sciences GILD | $22.74 B | 29.40% | ๐บ๐ธ USA |
Merck MRK | $37.63 B | 114.07% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $29.48 B | 67.72% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | $0.19 B | -98.91% | ๐บ๐ธ USA |